May Journal Club: Dopamine, vascular permeability, and inflammation as relates to endometrium, pelvic pain, and pregnancy loss

Dr. Carpentier shares his experience with and looks into the science behind the use of dexamphetamine treatment as a novel off-label treatment for a number of female chronic disorders that do not respond well to conventional therapy including recurrent pregnancy loss, inflammation, and ongoing pain.    The primary article of focus for this journal club, “The neurotransmitter dopamine modulates vascular permeability in the endothelium”, along with a list of references can be downloaded to accompany the webinar.